Trial Outcomes & Findings for Video Discharge Instructions for Fever and ED Recidivism (NCT NCT01655251)

NCT ID: NCT01655251

Last Updated: 2025-10-14

Results Overview

Number of repeat visits to the ED within 72 hours of initial visit for fever

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

273 participants

Primary outcome timeframe

72 hours

Results posted on

2025-10-14

Participant Flow

Participant milestones

Participant milestones
Measure
Intervention
Video (DVD) discharge instructions Intervention
Control
Written instructions only
Overall Study
STARTED
140
133
Overall Study
COMPLETED
140
133
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Video Discharge Instructions for Fever and ED Recidivism

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Intervention
n=140 Participants
Video (DVD) discharge instructions
Control
n=133 Participants
Written instructions only
Total
n=273 Participants
Total of all reporting groups
Age, Customized
Age
2.7 years
STANDARD_DEVIATION 3.0 • n=5 Participants
2.1 years
STANDARD_DEVIATION 2.4 • n=7 Participants
2.4 years
STANDARD_DEVIATION 2.7 • n=5 Participants
Sex: Female, Male
Female
72 Participants
n=5 Participants
74 Participants
n=7 Participants
146 Participants
n=5 Participants
Sex: Female, Male
Male
68 Participants
n=5 Participants
59 Participants
n=7 Participants
127 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
72 Participants
n=5 Participants
73 Participants
n=7 Participants
145 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
68 Participants
n=5 Participants
60 Participants
n=7 Participants
128 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
22 Participants
n=5 Participants
19 Participants
n=7 Participants
41 Participants
n=5 Participants
Race (NIH/OMB)
White
31 Participants
n=5 Participants
29 Participants
n=7 Participants
60 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
15 Participants
n=5 Participants
13 Participants
n=7 Participants
28 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
72 Participants
n=5 Participants
72 Participants
n=7 Participants
144 Participants
n=5 Participants

PRIMARY outcome

Timeframe: 72 hours

Number of repeat visits to the ED within 72 hours of initial visit for fever

Outcome measures

Outcome measures
Measure
Intervention
n=140 Participants
Video (DVD) discharge instructions
Control
n=133 Participants
Written instructions only
Recidivism
6 number of return visits within 72 ho
3 number of return visits within 72 ho

SECONDARY outcome

Timeframe: 1 week

Population: Parents were not considered enrolled but contributed to the assessment.

Rating of how useful the parents found the discharge instructions

Outcome measures

Outcome measures
Measure
Intervention
n=140 Participants
Video (DVD) discharge instructions
Control
n=133 Participants
Written instructions only
Usefulness
94 number of parents found useful
94 number of parents found useful

Adverse Events

Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Sharon R. Smith

Connecticut Children's Medical Center

Phone: 860-545-9000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place